Sequencing Oral SERDs: HR+/HER2- BC
Sequencing Novel SERDs in the Treatment of Patients With HR+/HER2- Metastatic Breast Cancer

Released: November 15, 2024

Expiration: November 14, 2025

Activity

Progress
1
Course Completed